Zydus Cadila Receives Us Fda Approval To Market Glycopyrrolate Injection
Zydus Cadila Has Received Final Approval From The Us Food And Drug Administration (Fda) To Market Glycopyrrolate Injection In The Strengths Of 0.2 Mg/Ml And 0.4 Mg/2 Ml (0.2 Mg/Ml) Single-Dose Vials And 1 Mg/5 Ml (0.2 Mg/Ml) And 4 Mg/20 Ml (0.2 Mg/Ml) Multiple-Dose Vials, (Us Rld: Robinul). Glycopyrrolate Is Used Before Surgery To Decrease The Volume Of Secretions From Mouth, Lungs And Stomach. It Can Also Be Used Either Before Or During Surgery To Maintain Heart
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!